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A NEW RIBONUCLEOTIDE REDUCTASE INHIBITOR, 
(E)-2'-DEOXY-(FLUROMETHYLENE) CYTIDINE, ACTS AS A 
RADIOSENSITIZER ON HUMAN COLON AND CERVIX CANCER 
CELL LINES 
P.A. Coucke, Y.X. Li, E. Cottin, L Agustoni, N. Paschoud, A. Noel and 
R.O. Mirimanoff 
Dep',u'tment of Radiation Oncology, Laboratory of Radiobiology, Centre 
Hospitalier Universitaire Vaudois, Lausanne, Switzerland. 
Background : Ribonucleotide Reductase (RR) inhibitors such as 
Gemcitabline (dFdC) and Hydroxyurea (HUt are known to act as 
radiosensitizers both in vitro and in vivo. More recently, (E)-2'-Deoxy- 
(Fluoromethylene) cytidine (FMdC) has been developed as an RR-inhibitor. 
It is a cytotoxic drug in vitro and in vivo. 
Purpose : To determine if at low doses of FMdC InM concentrations) a 
radiation sensitizing effect can be observed in human cancer cell lines of 
colon (WiDr) and cervix origin (SiHa, C4-1 and C33-A) and to investigate 
the cell cycle effects of FMdC after irradiation by flow cytometry. 
Material and methods : Postradiation surviving fraction has been evaluated 
by clonogenic assay. Postirradiation cell cycle distribution of WiDr has 
been evaluated by flow cytometry (double labelling with propidium iodine 
and bromodeoxy-uridine). Data were considered significantly different if a 
0.05 p-value was reached (two-sided t-test). 
Results :
WiDr C4-1 C33-A SiHa 
SF-2 (control) 77:£ '6 .8 45.7:!:3.9 62.6+1.9 64.9-',=.5.5 
SF-2 (FMdC) 37+7.9* 18.5-+-5.3 # 39-,2_4.5 ~ 38.8::t.3 t 
DMF-50 2.3 25 1.7 1.7 
DMF- I 0 1.6 1.5 1.4 1.4 
SF-2 values are expressed in % and tabulated with corresponding standard 
error. DMF-10/50: dose-modifying factor at 10% or 50% survival level : (*) 
FMdC at 50 nM; (#) FMdC at 40 nM and @) FMdC at 30 riM. The 
differences observed between SF-2 (Control) and SF-2 (FMdC), are all 
statistically significant. DMF-values were estimated from the complete 
dose-response curves. Flow cytometry done on WiDr, shows accumulation 
of irradiated cells in G2/M. This accumulation is increased by the use of 
FMdC. 
Conclusion : In nanomolar concentrations FMdC is cytotoxic and acts as a 
radiosensitizer in vitro on colon and cervix cancer cell lines. We are 
currently investigating the effects in vivo and the cell cycle machinery 
regulating the G2/M transition (cyclin B, p34 cdc2, wee-I and cdd25). 
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Residual DNA strand breaks and cellular 
radiosensitivity of 9 mammalian cell lines 
Ingo Brammer,  J. Dahm-Daphi ,  E. Dikomey 
Institute of Biophysics and Radiobiology, University of Hamburg, Germany 
Background:  The radiosensitivity of  proliferating mammalian cells 
is mainly determined by the rate of  mitotic death. X-irrediated cells 
ending in mitotic death die from chromosomal aberrations. Lethal 
aberrations arise from DHA double-strand breaks (dsb). Therefore, 
the number of  residual dsb observed after the end of  repair may be an 
indicator of  the number of  nonrepairable thal lesions, i.e. o f  the 
cellular radiosensitivity. 
Purpose: For 9 mammalian cell lines, the residual numbers of dsb as 
well as of  single-strand breaks (ssb) were measured and compared 
with cell survival. 
Mater ial  and methods: Human normal fibroblasts, AT fibroblasts, 
CHO, Cl iO KI,  x.rsl, xrsS, Ri l l ,  bulb and scid cells in culture were 
irradiated with X-rays. The cellular radiosensitivity was measured 
by colony assay, dsb were determined by constant-field gel electro- 
phoresis, ssb by the alkali unwinding method. 
Results: The 9 cell lines showed a broad spectrum of cellular radio- 
sensitivity (Do ranging from 0.5 to 1.3 Gy). The numbers of  dsb as 
well as of  ssb induced (immediately after irradiation) showed no 
difference between the cell lines. In contrast, we found a great 
variance for the numbers of  residual breaks (measured after 24 hours 
of  repair). The numbers were compared with radiosensitivity: in 
radiosensitive cells a higher number of  residual breaks was found 
when compared to radioresistant cells. This holds for dsb as well as 
for ssb. However, the correlation was better for dsb than for ssb. 
Conc lus ion :  For the 9 cell lines studied, the cellular radiosensitivity 
is correlated with the number of  residual DNA double-strand breaks 
as well as of  single-strand breaks. 
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RAI)IOSI.:NSI'I'IVI'rY OF MCF7 IItJM^N BREb.,"-;T CANUI.:R CELI.S IN 
MONOI.AYER AND SPlIEROII) CUI.TURE: EFFI.ICTS OF 
FRA(YI'IONATH) IRADIA'I'ION. 
Aranda M. Vdlalobos M . P, tr~vra I). (;utrado I). 'l'orrc'z 13. I'tYe'.,. P, Olea 
N . Ptxlra~'zl V Ih-'partamcmt of [~adlology. ~ch(xtl of M(~h~.~nc. Ilnr~rrstty 
of Granada 18071 Granada. ,';pare 
'l'hc aim of Lh]s study was to mve'~tt,qate Lh t.vllular radmsfmsltwlty or 
trstrof.len sensltt~ brt~st cancer cells m a three dimensional model undc'r 
fully t)xlc (xmdtLlons using Lrradtatlon schedules vnth one and three 
fracttons. (:cllular adt(rsc~sltwlty ( ~ and 15 values ofLhe hnear quadratic 
m(x'lel and 2 (.;y survwmg fraction 5F2Gy) and radiatton mducl~l )NA 
damage (double strand br¢:ak, dsb) stu(ht~ m the sphertnd mtxlel of M ('F7 
human hr~st ~nct1" ~lls were compared to monolayer cultures. Grown as 
multtcellular spher¢~ds, MCF 7 ~lls showc~l a reduced radlosensttwlty (ct 
{] 1,19Gy 1,13 O{E'~I Gy2.SF'2 7f)~; a~/[5 .'1.8; mltlal DNAdamage 
130 dshK;ylI)NA untt) when t.ompared to monola~,,m" culturtm (tz 0 316 
t;y 1.15 0023 Gy 2. (z/l:g 137 and 5F2Gy 50%. and mtLtal DNA 
damatJe 27_', dsbK;y/1)NA untL) The radio protL~la,~ effecL or the Lhree 
dtmenslonal culture was re',cz'rs(~ mLilt" fracl.tonat~'d mradtatlon st:hedulc's. 
Alter a 30 31 ~'~ (;y li'aO.toned trt~ttment with a 24 h mterval between 
fraction. MCF 7 cells showcxl an mo'e'~se m the surwvm,t] fraOaon (51: 
{1 (X)3~6 fir. 9 (;y sml,le dos(: ~. 5F 0.6~ f(n" 31 31 3 Gy treatment) ew:n 
though tilts was act~mpan ictl by an increase m ~)lular adlosensltwlty (5F2 
40~6. DNA dama qe 2.52 dsbK;y/I)NA umt) Cell cycle analysts using 
Ilow (.),k)meLry of props(hum iodure stained ccU nuclei demonstraded the 
mductton of a (;2 block by a/raO.tonal.exl dose of Lhree 3 Gy fraO.tons Our 
findings mdtcaLe that 1) senmLt~ty to radlatton and the proptn'Lion t)f 
proh feraLmg ¢arlls are probably related, and 2) d t ffcrenc'es mradn)sensttwlty 
reflect dtl]'t.TenC:os m rachaLton mdu~xl I)NA damage 
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NORMAL TISSUE RADIOSENSITIVTY AND LOCAL - 
CONTROL IN BREAST CANCER PATIENTS WITH 
POSTMASTECTOMY RADIOTHERAPY 
Thomas Kuhnt, Christine Richter, Axel Becker, Jiirgen Dunst 
Martin-Luther-University Halle-Wittenberg, Dept. of Radiotherapy 
06097 Halle, Germany. 
Background : We have retrospectively investigated variations in 
normal tissue reactions and local control in breast cancer patients. 
Materials and methods : From 1985 through 1991, 194 patients with 
breast cancers pTI-2pNO-2M0 received adjuvant postmastectomy 
radiotherapy alone without chemotherapy. The chest wall was 
irradiated with 9 MV-electrons with daily doses of 2 Gy up to 44 Gy, 
the lymphatics with an anterior 9 MV-photon field with daily fractions 
of 2 Gy up to 50 Gy. Side effects were evaluated once weekly during 
treatment and thereafter twice yearly. 
Results : Skin erythema was mild in 98 patients (51%), moderate in 
53 (27%) and severe in 43 (22%). 38 patients (20%) developed 
clinical signs of esophagitis, 13 (7%) asymptomatic and 58 (30%) 
symptomatic pneumonitis during radiotherapy. The frequency of late 
sequelae (mild to moderate, overall 17%) did not correlate with acute 
reactions. If patients were divided in 3 subgroups according to the 
degree of acute reactions, patients with minimal reactions had a 
significant higher probability of developing a local recurrence than 
patients with severe reactions (5/72 vs. 0/58 local recurrences, 
p<0.05). 
Conclusions: The correlation between acute radiation reactions and 
local control suggests a linkage between ormal and malignant tissue 
radiosensit ivity and supports the hypothesis that genetical ly 
determined differences in radiosensitivity may be clinically relevant. 
